During the past decade, Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 14 clinical trials were completed, i.e. on average, 24.6% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 5 clinical trials were completed. i.e. 15.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Inonu University" with 13 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Abbott Nutrition" with 2 trials sponsored and "Diskapi Teaching and Research Hospital" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" #1 collaborator was "Zai Lab (Shanghai) Co., Ltd." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" are "Non-Small Cell Lung Cancer" (6 trials), "Neoplasm Metastasis" (4 trials), "Breast Cancer" (3 trials), "Surgery" (3 trials) and "Anemia" (2 trials). Many other conditions were trialed in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" in a lesser frequency.

Most popular intervention types in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" are "Drug" (52 trials), "Other" (7 trials), "Biological" (5 trials), "Device" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Atezolizumab" (9 trials), "Cisplatin" (9 trials), "Carboplatin" (5 trials) and "Pembrolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department" are 66 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department". undefined are not yet recruiting, 17 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 9 trials that are defined as “Not Applicable".